Fighting diseases of global impact
The Institute for Glycomics, founded over 19 years ago, was so named due to its multidisciplinary research approach centred around glycomics.
Our unique research expertise makes us the only institute of its kind in Australia and only one of a handful in the world. We seek to collaborate with leading scientists around the world to build a critical mass around this multidisciplinary research. Global collaboration is essential to achieving our vision to bring forward novel drugs and vaccines to the community.
What is glycomics?
Glycomics is the study of the carbohydrate or sugar language within our body, referred to as the ‘glycome’. Every cell in our body is decorated with these sugars, which are essential to our health and wellbeing.
These simple sugar molecules connect together to create powerful structures called ‘glycans’. Cancers and infectious diseases can take advantage of glycans, resulting in major health problems and potentially death.
The study of sugars – glycomics – is a relatively new field of study compared with genomics (the study of genes) and proteomics (the study of proteins). However, glycomics is now a rising star thanks to the development of new tools to effectively identify sugar structures and their involvement in disease.
Our research focusses on the role that sugars play in disease and, using that knowledge, invent new drugs, vaccines and diagnostics to treat, prevent or diagnose cancer and infectious diseases.
“To be a world-leader in the discovery and development of drugs, vaccines and diagnostics through the application of innovative multidisciplinary science in a unique research environment.”
“Fighting diseases of global impact through discovery and translational science.”
A major research theme is discovering the role that carbohydrates play in disease and with that knowledge to develop new drugs and vaccines which will interfere with the biological process of disease. We provide a multidisciplinary approach to research and education, spanning medicinal and computational chemistry, various biological and physical sciences. This approach presents an exciting platform for the control of a wide-range of medical conditions such as infectious disease, cancer and other disorders.
Institute for Glycomics Director appointed high honour of Officer of the Order...
11 Jun 2019
Professor Mark von Itzstein, Founder and Director of Griffith University’s Institute for Glycomics,...
Griffith University research partnership breaking new ground in the development...
30 May 2019
Scientists from Griffith’s Institute for Glycomics have teamed up with Germany’s Fraunhofer...
Cheers – charge your glass with a Griffith scientist
20 May 2019
Science will be on tap when researchers trade the lab for the pub.
Institute for Glycomics shares in multi-million dollar grant for...
14 May 2019
The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes...
Glycomics Circle – empowering women in science
02 May 2019
The Institute for Glycomics recognises the value of having women in life sciences. For centuries...
Malaria vaccine trial receives $500,000 in Government support
11 Mar 2019
The Liberal National Government has announced they will donate $500,000 to Griffith University’s...